SpringWorks Therapeutics, Inc. SWTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

57/100

4/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Metric	TTM (2024-06 – 2025-03)
Operating Cash Flow	$-165.43M
Capital Expenditure	$-8.9M
Free Cash Flow	$-174.33M

People Also View

RVMD

Revolution Medicines, Inc.

$152.54

+3.76%

BPMC

Blueprint Medicines Corporation

$129.46

+0.14%

CERE

Cerevel Therapeutics Holdings, Inc.

$44.96

+0.74%

KYMR

Kymera Therapeutics, Inc.

$89.00

-0.96%

APLS

Apellis Pharmaceuticals, Inc.

$40.85

-0.01%

TERN

Terns Pharmaceuticals, Inc.

$52.71

+0.06%

MRTX

Mirati Therapeutics, Inc.

$58.70

-0.17%

RLAY

Relay Therapeutics, Inc.

$15.49

+5.02%

SpringWorks Therapeutics, Inc. SWTX NASDAQ

People Also View

Get Undervalued Stock Alerts